
|Articles|February 3, 2022
Analysis of Antibody Drug Conjugates
Author(s)Agilent Technologies, Inc.
This application note describes the drug-to-antibody determination of brentuximab vedotin using a ternary gradient with isopropanol as third channel organic modifier.
